US 9326991
Nucleotide prodrug compounds and use
granted A61KA61K31/7056A61K45/06
Quick answer
US patent 9326991 (Nucleotide prodrug compounds and use) held by Ligand Pharmaceuticals Incorporated expires Mon Apr 28 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Ligand Pharmaceuticals Incorporated
- Grant date
- Tue May 03 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 28 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 22
- CPC classes
- A61K, A61K31/7056, A61K45/06, A61P, A61P31/12